Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Tissue Heart Valves Overview 8
3 Products under Development 9
3.1 Tissue Heart Valves – Pipeline Products by Stage of Development 9
3.2 Tissue Heart Valves – Pipeline Products by Segment 10
3.3 Tissue Heart Valves – Pipeline Products by Territory 11
3.4 Tissue Heart Valves – Pipeline Products by Regulatory Path 12
3.5 Tissue Heart Valves – Pipeline Products by Estimated Approval Date 13
3.6 Tissue Heart Valves – Ongoing Clinical Trials 14
4 Tissue Heart Valves – Pipeline Products under Development by Companies 15
4.1 Tissue Heart Valves Companies – Pipeline Products by Stage of Development 15
4.2 Tissue Heart Valves – Pipeline Products by Stage of Development 16
5 Tissue Heart Valves Companies and Product Overview 18
5.1 Abbott Vascular Inc Company Overview 18
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Children’s Hospital Boston Company Overview 21
5.2.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Colibri Heart Valve LLC Company Overview 22
5.3.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 CorMatrix Cardiovascular Inc Company Overview 24
5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 CroiValve Ltd Company Overview 29
5.5.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 CryoLife Inc Company Overview 30
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 32
5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Daidalos Solutions BV Company Overview 33
5.8.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Edwards Lifesciences Corp Company Overview 36
5.9.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Hancock Jaffe Laboratories Inc Company Overview 42
5.10.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 LivaNova PLC Company Overview 44
5.11.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.12 Medtronic plc Company Overview 49
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49
5.13 Revivicor Inc Company Overview 51
5.13.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 52
5.14.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 52
5.15 Stellenbosch University Company Overview 53
5.15.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 53
5.16 Tissue Regenix Ltd Company Overview 54
5.16.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
5.17 University of California Irvine Company Overview 56
5.17.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 56
5.18 University of Cambridge Company Overview 58
5.18.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 University of Minnesota Company Overview 59
5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 59
5.20 University of Zurich Company Overview 60
5.20.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 60
5.21 Valcare Medical Company Overview 61
5.21.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.22 ValveXchange, Inc. (Inactive) Company Overview 62
5.22.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
5.23 VueKlar Cardiovascular Ltd (Inactive) Company Overview 65
5.23.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65
6 Tissue Heart Valves- Recent Developments 66
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 66
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 68
6.3 Oct 30, 2019: OmniGuide Holdings hires Giorgio Brusa as VP Global Marketing and Matthew Rice as Managing Director, OmniGuide Surgical Strategic Business Unit 69
6.4 Oct 30, 2019: LivaNova reports third quarter 2019 results 70
6.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 71
7 Appendix 125
7.1 Methodology 125
7.2 About GlobalData 128
7.3 Contact Us 128
7.4 Disclaimer 128
Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 2: Tissue Heart Valves - Pipeline Products by Segment
Table 3: Tissue Heart Valves - Pipeline Products by Territory
Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Tissue Heart Valves - Ongoing Clinical Trials
Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Expanded Clinical Study of the Tendyne Mitral Valve System
Table 15: Tendyne Bioprosthetic Mitral Valve Implantation System - Feasibility Study of the Tendyne Mitral Valve System for Use in Subjects with Mitral Annular Calcification
Table 16: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Heart Valve Leaflet - Product Status
Table 18: Heart Valve Leaflet - Product Description
Table 19: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Pulmonary Valve - Product Status
Table 21: Pulmonary Valve - Product Description
Table 22: Sutureless Surgical Aortic Valve - Product Status
Table 23: Sutureless Surgical Aortic Valve - Product Description
Table 24: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: CorMatrix Cor TRICUSPID ECM Valve Device - Product Status
Table 26: CorMatrix Cor TRICUSPID ECM Valve Device - Product Description
Table 27: CorMatrix ECM - Heart Valve Repair - Product Status
Table 28: CorMatrix ECM - Heart Valve Repair - Product Description
Table 29: CorMatrix ECM - Heart Valve Replacement - Product Status
Table 30: CorMatrix ECM - Heart Valve Replacement - Product Description
Table 31: Regenerating Tubular Mitral Valve - Product Status
Table 32: Regenerating Tubular Mitral Valve - Product Description
Table 33: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
Table 34: CorMatrix Cor TRICUSPID ECM Valve Device - CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility
Table 35: CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Tricuspid Valve Replacement Device - Product Status
Table 37: Tricuspid Valve Replacement Device - Product Description
Table 38: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: CryoValve SGAV - Product Status
Table 40: CryoValve SGAV - Product Description
Table 41: Synergraft Xenograft Heart Valve - Product Status
Table 42: Synergraft Xenograft Heart Valve - Product Description
Table 43: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Cytograft Valve - Product Status
Table 45: Cytograft Valve - Product Description
Table 46: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Sutureless Aortic Valve Prosthesis - Product Status
Table 48: Sutureless Aortic Valve Prosthesis - Product Description
Table 49: Sutureless Mitral Valve Prostheses - Product Status
Table 50: Sutureless Mitral Valve Prostheses - Product Description
Table 51: Sutureless Tricuspid Valve Prostheses - Product Status
Table 52: Sutureless Tricuspid Valve Prostheses - Product Description
Table 53: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 54: GLX Aortic Conduit - Product Status
Table 55: GLX Aortic Conduit - Product Description
Table 56: INTUITY Valve System - Product Status
Table 57: INTUITY Valve System - Product Description
Table 58: Konect AVC - Product Status
Table 59: Konect AVC - Product Description
Table 60: Magna EASE Surgical Valve With GLX - Product Status
Table 61: Magna EASE Surgical Valve With GLX - Product Description
Table 62: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 63: INTUITY Valve System - Impact of SAVR and TAVR on Patient's Activity and Mobility CAPABILITY Study
Table 64: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
Table 65: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve
Table 66: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
Table 67: Magna EASE Surgical Valve With GLX - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE
List of Figures
Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Figure 2: Tissue Heart Valves - Pipeline Products by Segment
Figure 3: Tissue Heart Valves - Pipeline Products by Territory
Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Heart Valves - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer